Collegium Pharmaceutical (COLL) Net Equity Issued and Repurchased (2015 - 2017)

Collegium Pharmaceutical's Net Equity Issued and Repurchased history runs 3 years deep, the most recent figure standing at $24.9 million for Q4 2017.

• On a quarterly basis, Net Equity Issued and Repurchased fell 70.94% year-over-year to $24.9 million in Q4 2017; TTM through Dec 2017 was $111.1 million, a 19.12% decrease from a year earlier, with the FY2018 full-year figure at -$30000.0, down 100.09% from the prior year.
• Net Equity Issued and Repurchased eased to $24.9 million in Q4 2017 per COLL's latest filing, from $85.7 million in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $85.7 million in Q4 2016 and bottomed at $445000.0 in Q3 2016.
• The 3-year median for Net Equity Issued and Repurchased is $50.0 million (2015), against an average of $42.5 million.
• Across the five-year window, Net Equity Issued and Repurchased advanced 2.35% in 2016 and plunged 70.94% in 2017, its largest moves.
• Year by year, Net Equity Issued and Repurchased stood at $50.0 million in 2015, then soared by 71.44% to $85.7 million in 2016, then plunged by 70.94% to $24.9 million in 2017.
• Per Business Quant, the three latest COLL Net Equity Issued and Repurchased figures stand at $24.9 million (Q4 2017), $85.7 million (Q4 2016), and $445000.0 (Q3 2016).